BLT 0.00% 2.6¢ benitec biopharma limited

Does anyone foresee any further value catalysts for the...

  1. 2,820 Posts.
    lightbulb Created with Sketch. 618
    Does anyone foresee any further value catalysts for the remainder of 2018?.

    First quarter 2019 looks very busy from BB-401 interim results, OPMD milestone announcements, new proprietary program, and news about the remaining four joint programs with Axovant. Have I missed anything?
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.